R.A. Session II

TSHA

R.A. Session II serves as an insider at Taysha Gene Therapies, Inc. (TSHA). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$529.1K

Total Sells

3 trades

$388.7K

Net Position

Net Buyer

$140.4K

Companies Traded

TSHA

Active Period

Dec 2021 – Jul 2023

4 total trades

Most Recent

Sell TSHA

Jul 14, 2023 · $60.8K

R.A. Session II's Insider Trading at Taysha Gene Therapies, Inc. (TSHA)

Buys

1 · $529.1K

Sells

3 · $388.7K

Total Shares Bought

42,518

Total Shares Sold

549,095

TSHA Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jul 14, 2023	Sell	85,872	$0.71	$60.8K	8,877,091
Jun 26, 2023	Sell	28,608	$0.70	$20.1K	8,975,719
Jun 22, 2023	Sell	434,615	$0.71	$307.8K	9,125,189
Dec 8, 2021	Buy	42,518	$12.44	$529.1K	9,190,920

Related Insiders

Sukumar Nagendran

President and Head of R&D

TSHASell · Apr 13, 2026

Kamran Alam

CHIEF FINANCIAL OFFICER

TSHASell · Feb 4, 2026

Sean P. Nolan

Chief Executive Officer

TSHASell · Jan 23, 2026

Explore More Insider Trading Data

TSHA Insider Trading Activity

View all insider trades at Taysha Gene Therapies, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity